{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:02:08Z","timestamp":1792627328375,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011913","name":"Kaohsiung Veterans General Hospital","doi-asserted-by":"publisher","award":["VGHNSU111-013"],"award-info":[{"award-number":["VGHNSU111-013"]}],"id":[{"id":"10.13039\/501100011913","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.bcp.2023.115494","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T03:11:22Z","timestamp":1678849882000},"page":"115494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Cytarabine-induced destabilization of MCL1 mRNA and protein triggers apoptosis in leukemia cells"],"prefix":"10.1016","volume":"211","author":[{"given":"Jing-Ting","family":"Chiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Chi","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Chung","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Chin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-Sen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2023.115494_b0005","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","article-title":"Acute myeloid leukemia: current progress and future directions","volume":"11","author":"Kantarjian","year":"2021","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.bcp.2023.115494_b0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.clml.2014.08.006","article-title":"Progress in acute myeloid leukemia","volume":"15","author":"Kadia","year":"2015","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.bcp.2023.115494_b0015","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2017-04-777722","article-title":"Cytarabine dose in the consolidation treatment of AML: a systematic review and meta-analysis","volume":"130","author":"Magina","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2023.115494_b0020","first-page":"1731","article-title":"Intracellular metabolism of Ara-C and resulting DNA fragmentation and apoptosis of human AML HL-60 cells possessing disparate levels of Bcl-2 protein","volume":"10","author":"Bullock","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2023.115494_b0025","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1021\/bi00643a023","article-title":"Inhibition of deoxyribonucleic acid chain initiation: a new mode of action for 1-\u03b2-D-arabinofuranosylcytosine in human lymphoblasts","volume":"16","author":"Fridland","year":"1977","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2023.115494_b0030","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2016833118","article-title":"Enhanced cytarabine-induced killing in OGG1-deficient acute myeloid leukemia cells","volume":"118","author":"Owen","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bcp.2023.115494_b0035","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1159\/000513696","article-title":"Deoxycytidine kinase (DCK) mutations in human acute myeloid leukemia resistant to cytarabine","volume":"144","author":"Wu","year":"2021","journal-title":"Acta Haematol."},{"key":"10.1016\/j.bcp.2023.115494_b0040","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1158\/0008-5472.CAN-07-5528","article-title":"Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells","volume":"68","author":"Cai","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2023.115494_b0045","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41419-019-1626-x","article-title":"Surmounting cytarabine-resistance in acute myeloblastic leukemia cells and specimens with a synergistic combination of hydroxyurea and azidothymidine","volume":"10","author":"Levin","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2023.115494_b0050","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","article-title":"Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism","volume":"7","author":"Farge","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bcp.2023.115494_b0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00002018-199005010-00003","article-title":"The toxicity of cytarabine","volume":"5","author":"Stentoft","year":"1990","journal-title":"Drug Saf"},{"key":"10.1016\/j.bcp.2023.115494_b0060","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1200\/JCO.1991.9.4.679","article-title":"Cytarabine and neurologic toxicity","volume":"9","author":"Baker","year":"1991","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcp.2023.115494_b0065","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1182\/blood-2011-07-367557","article-title":"RNAi screening of the kinome with cytarabine in leukemias","volume":"119","author":"Tibes","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2023.115494_b0070","doi-asserted-by":"crossref","first-page":"41950","DOI":"10.1038\/srep41950","article-title":"Mechanisms responsible for the synergistic antileukemic interactions between ATR inhibition and cytarabine in acute myeloid leukemia cells","volume":"7","author":"Ma","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2023.115494_b0075","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1158\/1078-0432.CCR-15-3057","article-title":"Binding of released Bim to Mcl-1 is a mechanism of intrinsic resistance to ABT-199 which can be overcome by combination with daunorubicin or cytarabine in AML cells","volume":"22","author":"Niu","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2023.115494_b0080","doi-asserted-by":"crossref","first-page":"21230","DOI":"10.1038\/s41598-021-00733-5","article-title":"CD157 signaling promotes survival of acute myeloid leukemia cells and modulates sensitivity to cytarabine through regulation of anti-apoptotic Mcl-1","volume":"11","author":"Yakymiv","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2023.115494_b0085","doi-asserted-by":"crossref","first-page":"56811","DOI":"10.18632\/oncotarget.10796","article-title":"Inhibition of Mnk enhances apoptotic activity of cytarabine in acute myeloid leukemia cells","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2023.115494_b0090","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41419-022-04810-z","article-title":"Artesunate improves venetoclax plus cytarabine AML cell targeting by regulating the Noxa\/Bim\/Mcl-1\/p-Chk1 axis","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2023.115494_b0095","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13045-021-01079-1","article-title":"Targeting MCL-1 in cancer: current status and perspectives","volume":"14","author":"Wang","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bcp.2023.115494_b0100","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/s42003-021-02564-6","article-title":"The multiple mechanisms of MCL1 in the regulation of cell fate","volume":"4","author":"Widden","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bcp.2023.115494_b0105","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.molonc.2014.09.008","article-title":"Obatoclax potentiates the cytotoxic effect of cytarabine on acute myeloid leukemia cells by enhancing DNA damage","volume":"9","author":"Xie","year":"2015","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bcp.2023.115494_b0110","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1158\/0008-5472.CAN-19-0515","article-title":"Targeting myeloperoxidase disrupts mitochondrial redox balance and overcomes cytarabine resistance in human acute myeloid leukemia","volume":"79","author":"Hosseini","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2023.115494_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109978","article-title":"BCL2 inhibitor ABT-199 and BCL2L1 inhibitor WEHI-539 coordinately promote NOXA-mediated degradation of MCL1 in human leukemia cells","volume":"361","author":"Chiou","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bcp.2023.115494_b0120","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3390\/ph15091066","article-title":"Carboxyl group-modified myoglobin induces TNF-\u03b1-mediated apoptosis in leukemia cells","volume":"15","author":"Lee","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bcp.2023.115494_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2019.114857","article-title":"Autophagic HuR mRNA degradation induces survivin and MCL1 downregulation in YM155-treated human leukemia cells","volume":"387","author":"Chiou","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115494_b0130","doi-asserted-by":"crossref","first-page":"7356","DOI":"10.1002\/jcp.30407","article-title":"NOXA-mediated degradation of MCL1 and BCL2L1 causes apoptosis of daunorubicin-treated human acute myeloid leukemia cells","volume":"236","author":"Chiou","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2023.115494_b0135","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s10495-016-1307-5","article-title":"Amsacrine-induced apoptosis of human leukemia U937 cells is mediated by the inhibition of AKT- and ERK-induced stabilization of MCL1","volume":"22","author":"Lee","year":"2017","journal-title":"Apoptosis"},{"key":"10.1016\/j.bcp.2023.115494_b0140","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.canlet.2018.06.019","article-title":"ABT-263-induced MCL1 upregulation depends on autophagy-mediated 4EBP1 downregulation in human leukemia cells","volume":"432","author":"Lee","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2023.115494_b0145","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2023.115494_b0150","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-genet-102108-134850","article-title":"The role of mitochondria in apoptosis*","volume":"43","author":"Wang","year":"2009","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.bcp.2023.115494_b0155","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/febs.13190","article-title":"BH3-only proteins: a 20-year stock-take","volume":"282","author":"Doerflinger","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.bcp.2023.115494_b0160","doi-asserted-by":"crossref","first-page":"10491","DOI":"10.1074\/jbc.M412819200","article-title":"Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells","volume":"280","author":"Weng","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2023.115494_b0165","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1177\/1535370214538745","article-title":"Caspase-dependent Mcl-1 cleavage and effect of Mcl-1 phosphorylation in ABT-737-induced apoptosis in human acute lymphoblastic leukemia cell lines","volume":"239","author":"Ryu","year":"2014","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.bcp.2023.115494_b0170","first-page":"149","article-title":"Susceptibility to cytosine arabinoside (Ara-C)-induced cytotoxicity in human leukemia cell lines","volume":"152","author":"Kanno","year":"2004","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bcp.2023.115494_b0175","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.celrep.2014.05.016","article-title":"The ROS\/SUMO axis contributes to the response of acute myeloid leukemia cells to chemotherapeutic drugs","volume":"7","author":"Bossis","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2023.115494_b0180","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3390\/antiox10060890","article-title":"NADPH oxidases (NOX): an overview from discovery, molecular mechanisms to physiology and pathology","volume":"10","author":"Vermot","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.bcp.2023.115494_b0185","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1182\/blood.V118.21.4258.4258","article-title":"NADPH oxidase regulates cytarabine-induced apoptotic death in acute myeloid leukemia cells","volume":"118","author":"Khan","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2023.115494_b0190","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.3390\/ijms20236003","article-title":"The role of reactive oxygen species in acute myeloid leukaemia","volume":"20","author":"Sillar","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2023.115494_b0195","doi-asserted-by":"crossref","first-page":"e94374","DOI":"10.1371\/journal.pone.0094374","article-title":"Inhibition of mTOR-dependent autophagy sensitizes leukemic cells to cytarabine-induced apoptotic death","volume":"9","author":"Bosnjak","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2023.115494_b0200","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/MMBR.00031-10","article-title":"Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases","volume":"75","author":"Cargnello","year":"2011","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.bcp.2023.115494_b0205","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/cr.2014.57","article-title":"Akt: a new activation mechanism","volume":"24","author":"Gao","year":"2014","journal-title":"Cell Res."},{"key":"10.1016\/j.bcp.2023.115494_b0210","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.4161\/cc.29584","article-title":"Phosphorylation of Akt at the C-terminal tail triggers Akt activation","volume":"13","author":"Liu","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bcp.2023.115494_b0215","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.cellsig.2013.05.021","article-title":"Cross talk between p38MAPK and ERK is mediated through MAPK-mediated protein phosphatase 2A catalytic subunit \u03b1 and MAPK phosphatase-1 expression in human leukemia U937 cells","volume":"25","author":"Liu","year":"2013","journal-title":"Cell Signal."},{"key":"10.1016\/j.bcp.2023.115494_b0220","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1158\/1541-7786.MCR-10-0325","article-title":"The RNA-binding protein HuR promotes glioma growth and treatment resistance","volume":"9","author":"Filippova","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bcp.2023.115494_b0225","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.1073\/pnas.0701297104","article-title":"Structural insights into the degradation of Mcl-1 induced by BH3 domains","volume":"104","author":"Czabotar","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bcp.2023.115494_b0230","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ccr.2010.04.024","article-title":"GSK-3 promotes conditional association of CREB and its coactivators with MEIS1 to facilitate HOX-mediated transcription and oncogenesis","volume":"17","author":"Wang","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2023.115494_b0235","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3390\/cells3020418","article-title":"MCL1 ubiquitination: unique regulation of an essential survival protein","volume":"3","author":"Mojsa","year":"2014","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2023.115494_b0240","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.seminhematol.2014.05.008","article-title":"Targeting BCL2 for the treatment of lymphoid malignancies","volume":"51","author":"Anderson","year":"2014","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.bcp.2023.115494_b0245","doi-asserted-by":"crossref","first-page":"17012","DOI":"10.1038\/sigtrans.2017.12","article-title":"Inhibition of Mcl-1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells","volume":"2","author":"Luedtke","year":"2017","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.bcp.2023.115494_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110812","article-title":"The effects of cytarabine combined with ginsenoside compound K synergistically induce DNA damage in acute myeloid leukemia cells","volume":"132","author":"Qi","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2023.115494_b0255","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1124\/mol.105.012716","article-title":"Gemcitabine-induced activation of checkpoint signaling pathways that affect tumor cell survival","volume":"68","author":"Karnitz","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115494_b0260","doi-asserted-by":"crossref","first-page":"25171","DOI":"10.1074\/jbc.M802851200","article-title":"ATR-dependent activation of p38 MAP kinase is responsible for apoptotic cell death in cells depleted of Cdc7","volume":"283","author":"Im","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2023.115494_b0265","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1038\/cddis.2011.134","article-title":"DNA damage induces reactive oxygen species generation through the H2AX-Nox1\/Rac1 pathway","volume":"3","author":"Kang","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2023.115494_b0270","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.biochi.2010.11.001","article-title":"New insight into the Nox4 subcellular localization in HEK293 cells: first monoclonal antibodies against Nox4","volume":"93","author":"Zhang","year":"2011","journal-title":"Biochimie"},{"key":"10.1016\/j.bcp.2023.115494_b0275","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3389\/fphys.2012.00412","article-title":"From form to function: the role of Nox4 in the cardiovascular system","volume":"3","author":"Chen","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bcp.2023.115494_b0280","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1046\/j.1471-4159.2001.00495.x","article-title":"CREB DNA binding activity is inhibited by glycogen synthase kinase-3\u03b2 and facilitated by lithium","volume":"78","author":"Grimes","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2023.115494_b0285","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1042\/BJ20141100","article-title":"An interplay between the p38 MAPK pathway and AUBPs regulates c-fos mRNA stability during mitogenic stimulation","volume":"467","author":"Degese","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2023.115494_b0290","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1128\/MCB.00210-09","article-title":"p38 Mitogen-activated protein kinase- and HuR-dependent stabilization of p21Cip1 mRNA mediates the G1\/S checkpoint","volume":"29","author":"Lafarga","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcp.2023.115494_b0295","doi-asserted-by":"crossref","first-page":"49298","DOI":"10.1074\/jbc.M407535200","article-title":"Prostaglandin A2-mediated stabilization of p21 mRNA through an ERK-dependent pathway requiring the RNA-binding protein HuR","volume":"279","author":"Yang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2023.115494_b0300","doi-asserted-by":"crossref","first-page":"e00535","DOI":"10.1128\/MCB.00535-16","article-title":"MCL-1 depletion impairs DNA double-strand break repair and reinitiation of stalled DNA replication forks","volume":"37","author":"Mattoo","year":"2017","journal-title":"Mol. Cell. Biol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223000850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223000850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:39:52Z","timestamp":1757770792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295223000850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":60,"alternative-id":["S0006295223000850"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115494","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytarabine-induced destabilization of MCL1 mRNA and protein triggers apoptosis in leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115494","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115494"}}